Objective. To investigate the production of cytokines by T cells in patients with rheumatoid arthritis (RA), reactive arthritis (REA) and osteoarthritis (OA).
The aetiology and pathogenesis of rheumatoid arthritis produced by other cell types such as fibroblasts, endothelial or even epithelial cells. Thus, in the inflamed (RA) are still unresolved. In recent years, analysis of cytokine production in RA has attracted particular synovium, monocytes as well as type A and type B synoviocytes have been shown to produce large amounts interest since many cytokines are involved in the regulation of the immune and the inflammatory response [1] .
of cytokines, particularly pro-inflammatory cytokines such as tumour necrosis factor alpha ( TNF-a), interleuAlthough cells of the immune system are considered to be their primary sources, several cytokines can also be kin (IL)-1 or IL-8 [2] [3] [4] . In contrast to the general agreement on the role of highly activated macrophages and synoviocytes in the pathophysiology of RA, the process should be assumed. However, although the of the knee joints. Informed consent was obtained from all patients. Control sera from 20 healthy subjects (age majority of synovial T cells bear an activated phenotype, as indicated by expression of MHC class II antigens, range 27-58 yr) were also analysed. only a few also express the IL-2 receptor [5, 6 ] . This, Detection of cytokines in serum and SF and the failure unambiguously to demonstrate significant production of lymphokine proteins in RA synovial
Immunoassays were employed for all cytokine measurements. Assays for IL-1, IL-2, IL-4 and IL-6 were tissue [3, [7] [8] [9] [10] [11] , has led to debate about the role of T cells in RA [12] [13] [14] [15] [16] .
obtained from R & D Systems (Abingdon, UK ), the assay for TNF-a was from Medgénix (Fleurus, In an attempt to further our understanding of the role of T lymphocytes in RA, we have analysed T-cellBelgium), the assay for TNF-b was from Bender MedSystems ( Vienna, Austria) and the assay for IFN-c derived cytokines in sera and synovial fluid (SF ) from patients with RA and other rheumatic disorders by was from Centocor (Malvern, PA, USA). All assays were carefully tested with respect to reproducibility (see immunoassays, and have also investigated cytokine expression in synovial membranes by immunohistobelow), and recovery of recombinant cytokines in spiked body fluid samples (three concentrations-low, medium chemical methods using single-and double-labelling techniques. The results obtained demonstrate that a and high, e.g. 30, 100 and 400 pg/ml-in three sera and SF each). Possible interference by RF was tested by relatively small subset of activated T cells in the RA synovial membrane produce lymphokines, particularly analysis of samples before and after absorption of RF on IgG agarose (Sigma, St Louis, MO, USA), as IL-2 and interferon gamma (IFN-c), suggesting their participation in the pathophysiological processes of RA.
described [18] . The limit of detection was defined as the minimum concentration which could be reproducibly measured, i.e. with <25% inter-assay variation. It must be noted that in all assays used, the detection limit
Patients and methods defined in this manner was higher than that given by Patients the manufacturers. Thus, reproducible detection limits were 10 pg/ml for IFN-c, 20 pg/ml for TNF-b, 25 pg/ml Synovial fluid was aspirated from knee joint effusions and blood samples drawn by venepuncture at the same for IL-1a and IL-1b, and 30 pg/ml for IL-2, IL-4, IL-6 and TNF-a. The specificity of the assays was assessed time. Thirty-three paired serum/SF samples were from 27 patients with RA (female/male: 22/5; median age by competition assays in which neutralizing anticytokine antibodies (obtained from Endogen, Boston, 59 yr, range 38-76 yr; median disease duration 5 yr, range 1-23 yr); 85% of the patients were rheumatoid MA, USA or from R & D Systems) were added to selected samples as described [19] . All positive and factor (RF ) positive. Patients with reactive arthritis (REA) and osteoarthritis (OA) served as disease conrandomly selected negative samples were measured a second time for confirmation of results, and the mean trols: 26 samples were obtained from 17 REA patients (female/male: 11/7; median age 34 yr, range 14-65 yr; value of the two determinations was used for statistical analysis. All cytokines were below the detection limit in median disease duration 5 months, range 2-42 months) and 15 samples were obtained from 15 patients with sera from healthy individuals. Most of the cytokine assays were validated by participating in the Cytokine OA (female/male 8/7; median age 60 yr, range 47-81 yr; median disease duration 3 yr, range 0.5-21 yr). RA was Consensus Study Group of the European Workshop for Rheumatology Research [20] . classified according to the 1987 revised criteria of the American College of Rheumatology [17] . REA was Tissue sections defined as seronegative oligoarthritis with cultural evidence of sexually transmitted disease or cultural and/or Synovial tissue was obtained from eight patients with RA and from five patients with OA at the time of knee serological evidence of Salmonella or Yersinia infection. OA of the knee joints was diagnosed clinically and joint surgery, and snap-frozen in isopentane cooled with dry ice immediately after excision. Cryostat sections radiologically. The majority of patients were treated with non-steroidal anti-inflammatory drugs (diclofenac, (4-6 mm) were air-dried for 1 day at room temperature. Sections were then fixed in ice-cold acetone for 10 min ibuprofen or oxicams). In addition, eight RA and one REA patient received glucocorticoids (<10 mg and used for immunohistochemistry. prednisone/day), and 15 RA patients were also on slowDetection of cytokines in synovial membranes acting anti-rheumatic drugs (methotrexate, gold salts or chloroquine). In all patients, joints were examined for For cytokine detection, affinity-purified rabbit polyclonal antibodies to IL-2, IL-4, IL-6, IFN-c and TNF-a pain and swelling, and the Ritchie index was determined. In RA patients, early morning stiffness was recorded in were used (Endogen, Boston, MA, USA). In addition, monoclonal antibodies to IL-2 (Dako), IL-4 and IL-2R addition. Laboratory parameters included haemoglobin, platelet count, white cell counts in peripheral blood and (Genzyme, Boston, MA, USA) were employed. Rabbit IgG ( Endogen) or isotype-matched monoclonal antibod-SF, serum iron, erythrocyte sedimentation rate ( ESR), C-reactive protein (CRP) and RF. All patients were ies (Dako and Becton-Dickinson) served as controls. Sections were incubated with the primary anti-cytokine seen at the out-patient clinic of the Centre for Rheumatic Diseases at Lainz Hospital and presented with effusions antibody for 60 min. After rinsing, endogeneous peroxi-dase was blocked with 0.3% hydrogen peroxide in Tris- Table 1 . Thus, almost 60% of RA sera contained measurable amounts of at least one of the cytokines analysed, buffered saline (10 m Tris-HCl, 140 m NaCl, pH 7.4) for 10 min. This was followed by 30 min incubation particularly IL-1a and IL-6 (found in 24 and 27% of the samples, respectively), but also IFN-c (15% of the with the second antibody, a biotinylated affinity-purified goat anti-rabbit IgG or biotinylated horse anti-mouse sera) and TNF-b (18%), whereas in sera from REA or OA patients cytokines were in general not found IgG. Then, sections were incubated with the VECTASTAIN@ABC reagent ( Vector, Burlingame, ( Table 1A) . In SF, however, cytokines were detected in all three patient groups ( Table 1B) . Comparing Tables CA, USA) for another 30 min. Colour was developed using diaminobenzidine (Sigma), leading to brown stain-1A and B, it can be seen that in RA patients the presence of a given cytokine in serum was usually associated with ing. Finally, slides were counterstained with haematoxylin or Mayer's Hämalaun solution (both from Merck, its presence in SF, a phenomenon not observed in REA or OA. Of interest, in nine of the 33 RA sera investiDarmstadt, Germany). gated, two or more cytokines were detectable and with Phenotyping of cells one exception these sera contained at least one T-cellMonoclonal antibodies to CD3, CD4, CD8, CD20, derived lymphokine (Table 1A) . Summarizing the data CD45RA and CD45RO were from Becton Dickinson, obtained with SF, RA was characterized by the presence Mountain View, CA, USA; antibodies to CD68 and to of TNF-a, IFN-c and IL-6; REA samples typically HLA-DR were from Dako, Glostrup, Denmark.
contained IFN-c and IL-6, and in OA patients only Isotype-matched, unrelated monoclonal antibodies IL-6 was detected. Thus, among these three most freserved as controls. Sections were incubated with the quently detected cytokines, TNF-a was the major disprimary antibody diluted between 1:20 and 1:100 in criminator between RA and the other two disorders. Tris-buffered saline for 60 min at room temperature.
Quantitative analysis. IFN-c was the most frequently After rinsing, alkaline phosphatase-labelled, affinitydetected lymphokine. Thus, the majority of SF from purified rabbit anti-mouse immunoglobulins (Dako)
RA and REA patients (72 and 85%, respectively) conwere applied as second antibody for 30 min, followed tained IFN-c (>10 pg/ml ) in contrast to SF from OA by incubation with the APAAP complex (Dako). Colour patients ( Fig. 1) . Although IFN-c levels in REA were was developed using Fast Blue (Sigma, St Louis, MO, in general somewhat higher than in RA, this difference USA) as substrate.
did not reach the level of statistical significance. However, concentrations >100 pg/ml were measured in Characterization of cytokine-producing cells eight REA, but in only two RA samples. Double-labelling experiments were performed by first IL-2, IL-4 and TNF-b were detected much less frestaining for cytokines, followed by immunophenotyping quently than IFN-c. Interestingly, and in contrast to the as described above. Thus, upon light microscopy, cytomonokines IL-6 and TNF-a (see below), SF levels of kine-expressing cells appeared brown and CD antigens these cytokines were similar to those measured in serum. stained blue. The percentage of cytokine-producing cells Thus, IL-2 was present in two serum/SF pairs and in of a given CD subset was calculated by determining the two additional SF (detection limit 30 pg/ml, range fraction of double-stained lymphocytes among all 36-107 pg/ml ), and IL-4 was detected in three serum/SF lymphocytes counted (~20 000 cells per cytokine and pairs and one additional SF (detection limit 30 pg/ml, patient) at 400-fold magnification. range 30-149 pg/ml ). Interestingly, IL-2 and IL-4 appeared to be associated with each other since five of Statistical analysis the six IL-2-positive samples also contained IL-4 Results of cytokine determinations were correlated with ( Table 1) . Finally, TNF-b was detected in nine RA serological and clinical parameters of disease activity.
patients (four SF/serum pairs, three SF, two sera) and The data obtained in all SF investigated were used for in four REA patients (one SF/serum pair, three SF ); analysis, even though some joint aspirates (maximally levels were similar in both diseases (detection limit two) were from the same patients at different points in 20 pg/ml, range 23-55 pg/ml ). time. Data were processed using the SAS package.
The monokines IL-1a, IL-1b, IL-6 and TNF-a were Group data are indicated as medians and ranges. The determined in order to investigate potential correlations Wilcoxon rank sum test was used to analyse differences with T-cell-derived cytokines ( Table 1) . The results were between groups. The non-parametric Kendall correlagenerally in line with the literature [2-4, 8, 10, 11] . tion coefficient was used to assess correlations between Briefly, IL-1a and IL-1b (>25 pg/ml ) were detected in cytokines and between cytokines and serological or~3 0% of patients with RA (26-182 pg/ml, median clinical parameters. In some analyses, x2 test (with Yates' 35 pg/ml ), but not in the other disorders. In contrast, correction when appropriate) was used.
high levels of IL-6 (400-80 000 pg/ml, median 4500 pg/ml ) were measured in virtually all SF from RA and REA patients, and also in~70% of OA patients,
Results
although levels were significantly lower than in the other two disorders (P < 0.01). In serum, however, IL-6 Cytokines in sera and synovial fluids Cytokine patterns. The cytokine patterns obtained for (>30 pg/ml ) was found in only 27% of RA patients, but not in REA and OA patients, and levels were much individual patients are shown in a qualitative manner in T 1. Cytokine patterns observed in (A) sera and (B) SF from RA patients. Samples are grouped according to the number of cytokines detected per sample. For comparison, the percentagesa of positive samples from patients with REA and OA are shown at the bottom (A) Cytokine patterns in sera from RA patients (r = 0.47, P < 0.0001; data not shown). These associations were seen even better in those cases where consecutive samples from individual patients (six RA and six REA, respectively) were available. Thus, changes of IFN-c, TNF-a and IL-6 generally occurred in parallel, and were accompanied by changes in parameters related to disease activity (such as ESR, CRP, platelet count and number of lymphocytes in the joint); these changes were usually more pronounced in patients with REA (Fig. 3) .
Correlation of cytokines with laboratory and clinical parameters. Apart from IL-6, which in RA and REA patients correlated with ESR and CRP (data not shown), none of the cytokines determined was associated with any clinical or serological variable analysed nor with disease duration, although TNF-a levels tended to be higher in RA patients with long-standing disease. There was also no obvious correlation with (glucocorticoid or methotrexate) treatment. In consideration of the short lower than in SF (31-86 pg/ml, median 46 pg/ml ). Finally, TNF-a (>30 pg/ml ) was measured in 70% of SF from RA patients (39-382 pg/ml, median 157 pg/ml ), but in only four SF from REA patients (P < 0.001 vs RA) and in none of the OA samples.
Correlations between cytokines. In RA patients, IFN-c levels in SF correlated with both those of TNF-a (r = 0.31, P < 0.01; Fig. 2 ) and IL-6 (r = 0.32, P < 0.01). TNF-a also correlated strongly with IL-6 F. 3. Consecutive levels of IFN-c, TNF-a and IL-6 in SF of a patient with RA (A) and a patient with REA (B) at the first visit (1) and 14 weeks later (2) . The observed decreases in cytokine levels were accompanied by clinical improvement (as determined by erythrocyte sedimentation rate, C-reactive pro-F. 2. Correlation between IFN-c and TNF-a levels in RA tein, platelet count, number of lymphocytes in SF ), which was more pronounced in the REA patient; this was one of the synovial fluids. The detection limits of the two assays (10 and 30 pg/ml, respectively) are indicated by dotted lines.
four TNF-a-positive REA patients. The average ratio of IFN-c:IL-4-producing cells was membranes from seven of the eight patients with RA were heavily infiltrated with CD3-positive T cells~2:1, but varied considerably between individual patients, ranging between 5:1 and 1:1. Remarkably, (100-700 cells per field at ×400 magnification). In accordance with the literature,~60-80% of T cells were T-cell-specific expression of TNF-a was comparable to that of IL-2, whereas IL-6 expression was similar to CD45RO+ and 40-60% expressed HLA-DR [5, 6, 13, 14] . The ratio of CD4:CD8 cells ranged from 2 to 2.5.
that of IFN-c. Thus, the ratio of TNF-a:IL-6-producing T cells was comparable to the ratio found for IFN-c Synovial membranes from four of the five OA patients contained only a few T cells. In contrast, in sections and IL-4. from the fifth OA patient, more pronounced T-cell infiltrates were present; however, clusters were much Discussion smaller than those seen in RA patients (10-100 cells per field). The CD4:CD8 ratio in OA patients was compar-
The involvement of T cells in the pathophysiology of RA has been heavily disputed in the past decade [12] [13] [14] [15] [16] . able to that seen in patients with RA.
Cytokine expression in synovial membranes. In Fig. 4 , Although it is well established that the rheumatoid synovium is infiltrated with T cells showing an activated single stainings for the cytokines IFN-c, IL-2 and IL-4 are shown in tissue sections from a patient with RA. phenotype (as indicated by the expression of MHC class II molecules and other activation markers), the majority The three lymphokines were typically produced by cells infiltrating the synovium and were not found within the of these cells appear to be in a state of unresponsiveness since they lack expression of the IL-2 receptor [5, 6 ] . lining layer. These lymphokine-expressing cells tended to occur in small clusters and were particularly found Moreover, data on the presence of lymphokines in RA synovial tissue and fluid are controversial: even though in perivascular locations in close proximity to endothelial cells. In contrast, IL-6 and TNF-a were found mRNA for T-cell-specific cytokines has been detected by some investigators, conclusive evidence for expression throughout the synovium, including the lining layer, as described ( [3, 21, 22] ; data not shown). Although some of cytokine proteins by synovial T cells is still scarce [3, [7] [8] [9] [10] [11] [22] [23] [24] [25] . sections from OA patients contained T-cell infiltrates, neither cytokines nor expression of IL-2R could be
The data presented here now unambiguously demonstrate cytokine production by T cells in the synovium of detected (not shown).
To determine the relative frequency (i.e. percentage) patients with RA. Thus, apart from detecting the Th1 cytokine IFN-c in the majority of SF, we have been and to characterize phenotypically cytokine-producing T cells, double stainings were performed using monoable to demonstrate directly expression of cytokine proteins by synovial membrane T cells using histochemclonal antibodies to CD3, CD4 and CD8. Pronounced expression of cytokines was seen in only~0.1-0.3% of ical methods. In contrast, in T-cell infiltrates from OA patients, cytokine expression was generally not observed all T cells investigated; however, within some T-cell aggregates, cytokines could be detected in up to 3% of nor could lymphokines be detected in their SF. Interestingly, cytokine expression was not only seen in the cells. Although cytokine-expressing cells stained relatively weakly for CD antigens [presumably because CD4-positive T-helper cells, but with similar (relative) frequency also in the CD8-positive population. With the anti-cytokine antibody (applied first) interfered with binding of the anti-CD antibody], double-labelled cells RA being a MHC II-associated disease, a pathophysiological involvement of CD8 cells has been largely negcan be seen in Fig. 5 where representative results obtained for IFN-c, IL-2 and IL-4 are shown. In general, lected so far, although these cells might play an important regulatory role [26 ] . Furthermore, one should also lymphokine-expressing cells were CD3 positive (or found within clusters of CD3-positive cells), belonged primarily bear in mind that CD8 cells are activated by endogeneous antigens presented by MHC I molecules which may to the CD4 population, and were typically seen in perivascular areas and in the more superficial layers of include both pathogen-derived and 'true' self structures. Compared to RA, the role of T cells in REA is less the synovial membrane. CD8-positive cells expressing cytokines were also detected, but were more diffusely controversial [27] . Therefore, it was somewhat surprising to find SF levels of IFN-c in REA and RA to be distributed, occurring also in the sublining zone either within small clusters or even as single cells. As expected, similar. This is in line with observations reported by Simon et al. [28] , who investigated cytokine mRNA IL-6 and TNF-a were produced mainly by CD68-positive cells; nevertheless, both cytokines also expression in synovial tissue, and suggests that both disorders bear substantial similarities as far as Th1 cells co-localized with CD3-positive T cells (Fig. 6) . [29]. Given that IFN-c is a potent activator of macrophages and (together with other stimuli) can induce or enhance TNF-a production [30] [31] [32] , one might also supported by recent observations in animal models [38, 39] . Our histochemical data may also point in this have expected high TNF-a levels in REA; however, this was not the case. Hence, IFN-c alone cannot be held direction since fewer cells stained positive for IL-4 than for IL-2 or IFN-c, even though IL-4-expressing T cells responsible for the chronic overproduction of TNF-a in RA, although the observed correlation between IFN-c were definitely seen in all RA patients investigated.
Determination of IL-4 in SF, on the other hand, did and TNF-a levels is suggestive of a mutual relationship between these two cytokines. It has been suggested by not provide further information since, in contrast to IFN-c, this cytokine (as well as IL-2 and TNF-b) was several authors that activation of Th2 cells, and thus production of anti-inflammatory cytokines such as IL-4, only rarely detected, most likely due to the lower sensitivity of the immunoassays used. In any case, cytokine may be deficient in RA and other autoimmune diseases [28, 33, 34] . This assumption is primarily based on in data must be interpreted with caution since it would probably be too simplistic a view to explain a complex vitro cytokine patterns of synovial T cells [35] [36] [37] and autoimmune disease like RA solely on the basis of a of patients suffering from leprosy or allergic contact dermatitis are well below 1%, and thus of the same order of Th1-Th2 imbalance.
In the light of the apparent pivotal importance of magnitude as the frequency of cytokine-expressing T cells reported here [45] [46] [47] .
(ii) RA is a disease strongly associ-TNF-a and IL-1 and their production by mesenchymal and myelomonocytic cells of the pannus [2] [3] [4] , it has been ated with certain MHC class II alleles, suggesting involvement of certain T-cell receptors [13, 15, 48] . (iii) T cells argued that the pannus was an autonomous tissue with macrophage-like cells being central to the pathogenic are already seen in the synovium at very early stages of RA and with progressing disease there appears to be little events, and that T cells entered the synovial membrane as 'innocent bystanders' rather than as cells specifically change of the synovium's immunohistological features [49] ; furthermore, cytokine-expressing (naive) T cells have involved in the inflammatory process [12, [40] [41] [42] . According to this assumption, T-cell activation would been observed in the peripheral blood of RA patients [50] .
(iv) Oligoclonality of synovial T-cell populations has been merely reflect a secondary phenomenon or just a reaction of T cells to the ongoing destructive process. Moreover, repeatedly described [51] [52] [53] [54] and germinal centre-like structures have been detected in RA synovial tissue [55] . the numbers of synovial T cells secreting cytokines could be regarded as being far too low to exert significant effects.
(v) Treatment directed towards T cells, such as therapy with cyclosporin A, can lead to significant clinical effects However, several lines of evidence suggest that T cells play an important role in the pathogenesis of RA. (i) It is in RA [56 ] and anti-CD4 monoclonal antibody therapy has been shown to lead to a decrease of monokines as well established that small numbers of antigen-specific T cells are sufficient to drive inflammatory (immune and well as to reduction of the inflammatory synovitis, including synovial lining cell hyperplasia [57] [58] [59] , although the autoimmune) processes [43, 44] . For example, the frequencies of antigen-specific T cells seen in the cerebrospinal clinical benefits obtained are debatable [60, 61] .
(vi) Furthermore, evidence has been provided recently fluid of patients with multiple sclerosis or in skin lesions tively few activated (Th1-like) cells could still be suffiInterestingly, T-cell membrane TNF-a was identified as cient to drive the autoimmune process. This does not one of the contact-mediated signals required for the reguexclude that with progressing disease the synoviocytes/ lation of IL-10 production. Our finding of TNF-a expresmonocytes become more and more autonomous, requirsion by synovial T cells suggests that this regulatory circuit ing less support by T cells. In therapeutic terms, this might be of relevance in RA. (vii) Most inducible animal would imply that interference with both cellular commodels of RA (and other autoimmune diseases too) partments is required for successful treatment of RA. appear to be T-cell dependent. Nevertheless, even in collaSuch a conclusion is supported by recent evidence of gen arthritis, substantial amounts of lymphokines are improved efficacy of combination therapies in experifound only in the early stage, whereas monokines largely mental models of arthritis as well as in human RA predominate at late stages when anti-T-cell therapy [71] [72] [73] . In this context, it may be interesting to note becomes less effective [65, 66 ] . Finally, a novel animal that treatment with depleting anti-CD4 antibody apparmodel has been described recently in which spontaneously ently does not affect IFN-c-secreting Th1 cells [74], developing RA-like inflammatory joint disease was which may (partially) explain the modest benefits observed in a mouse strain obtained by crossing a TCR achieved in most clinical anti-CD4 trials [60, 61, 73] . In transgenic mouse with the (diabetes-prone) NOD strain any case, the presence of cytokine-expressing T cells in [67] . In these animals, disease development was heavily RA synovium is suggestive of antigen-specific activation, dependent upon T cells, even though joint histology and the identification of relevant antigens will remain a showed an abundance of cells of the myeloid lineage and challenging task for future investigations. a cytokine profile similar to human RA.
Taken together, these observations allow the conclusion to be drawn that a relatively small number of 
